Table 5. All-cause mortality and AVG use compared to AVF

ModelHR95% CIP
a Stratified for the presence coronary artery disease and adjusted for age, gender, late referral, peripheral vascular disease, and cerebral vascular disease.
b Stratified for the presence coronary artery disease and adjusted for age, gender, late referral, peripheral vascular disease, and cerebral vascular disease plus PS.
c AVF, n = 281; AVG, n = 356.
Crude1.741.32 –2.28<0.001
Adjusteda1.501.13 –1.98<0.01
Adjusted + PSb1.551.15 –2.07<0.01
PS Matched Cohort (n = 637c)1.390.93 –2.070.11